Measures · C17 in 2019 · Part C · HD2 Managing Chronic (Long Term) Conditions
Rheumatoid Arthritis Management
Chronic ConditionsHealth PlanSource: HEDIS
- What it measures
- Percent of plan members with rheumatoid arthritis who got one or more prescriptions for an anti-rheumatic drug.
- How it's calculated
- The percentage of MA members who were diagnosed with rheumatoid arthritis during the measurement year (denominator), and who were dispensed at least one ambulatory prescription for a disease modifying anti-rheumatic drug (DMARD) (numerator).
- Data source
- HEDIS
- Measurement period
- 01/01/2017 – 12/31/2017
- Better when
- Higher
- Weight
- 1 (Process Measure)
- Star assignment
- Clustering
- Case-mix adjusted
- —
- In improvement measure
- Yes
- Used in CAI
- Yes
- HEDIS label
- Disease-Modifying Anti-Rheumatic Drug Therapy for Rheumatoid Arthritis (ART)
- Exclusions
Show
(optional) • A diagnosis of HIV (HIV Value Set) any time during the member’s history through December 31 of the measurement year. • A diagnosis of pregnancy (Pregnancy Value Set) any time during the measurement year. Contracts whose enrollment was at least 500 but less than 1,000 as of the July 2017 enrollment report and having measure score reliability less than 0.7 are excluded. Contracts whose enrollment was less than 500 as of the July 2017 enrollment report are excluded from this measure.- Disaster policy
- Higher measure star (2018-2019) for contracts with 25% or more enrolled affected
From the 2019 Star Ratings Technical Notes (CMS).
Cut points over time
Score needed to earn each star level. Part D thresholds differ for MA-PD and standalone PDP contracts.
2019 star distribution
Not rated: Plan not required to report measure (116); Plan too new to be measured (66); Not enough data available (58); No data available (47); Plan too small to be measured (39); Benefit not offered by plan (4)
Cut point bands
| Star year | Org type | 1★ | 2★ | 3★ | 4★ | 5★ |
|---|---|---|---|---|---|---|
| 2022 | MA | < 68 % | >= 68 % to < 75 % | >= 75 % to < 79 % | >= 79 % to < 85 % | >= 85 % |
| 2021 | MA | < 60% | >= 60% to < 74% | >= 74% to < 79% | >= 79% to < 84% | >= 84% |
| 2020 | MA | < 60% | ? 60% to < 74% | ? 74% to < 79% | ? 79% to < 84% | ? 84% |
| 2019 | MA | < 69% | ? 69% to < 76% | ? 76% to < 83% | ? 83% to < 89% | ? 89% |
| 2018 | MA | < 65% | ? 65% to < 72% | ? 72% to < 78% | ? 78% to < 86% | ? 86% |
| 2017 | MA | < 54% | ? 54% to < 72% | ? 72% to < 76% | ? 76% to < 82% | ? 82% |
| 2016 | MA | < 64% | ? 64% to < 75% | ? 75% to < 82% | ? 82% to < 86% | ? 86% |
| 2015 | MA | < 60% | ? 60% to < 71% | ? 71% to < 78% | ? 78% to < 88% | ? 88% |
Lowest-scoring contracts, 2019
| Contract | Parent | Members | Score | Stars | Δ | Shortfall to 4★ | Pctile |
|---|---|---|---|---|---|---|---|
| H5475 Wellcare | Centene Corporation | 18,951 | 58 | 1 | — | 25 | 0% |
| H3259 BlueCare Plus Tennessee | BlueCross BlueShield of Tennessee | 31,617 | 62 | 1 | 0 | 21 | 0% |
| H5580 Mercy Care Advantage | Mercy Care | 10,965 | 65 | 1 | −1 | 18 | 1% |
| H3962 Capital Blue Cross | CAPITAL BLUE CROSS | 8,238 | 66 | 1 | −2 | 17 | 1% |
| H8266 Constellation Health, Llc. | Constellation Health, LLC. | — | 66 | 1 | 0 | 17 | 1% |
| H3240 Wellpoint | Elevance Health, Inc. | 14,532 | 66 | 1 | −1 | 17 | 1% |
| H9730 Wellcare | Centene Corporation | 35,990 | 67 | 1 | 0 | 16 | 2% |
| H8133 Blue Cross and Blue Shield of Texas | Health Care Service Corporation | 2,507 | 67 | 1 | — | 16 | 2% |
| H2491 Wellcare | Centene Corporation | 9,861 | 67 | 1 | 0 | 16 | 2% |
| H5587 Blue Cross Blue Shield of Arizona Health Choice | Blue Cross Blue Shield of Arizona | 8,603 | 67 | 1 | −1 | 16 | 2% |
| H0251 UnitedHealthcare | UnitedHealth Group, Inc. | 76,188 | 67 | 1 | −1 | 16 | 2% |
| H8854 CareFirst BlueCross BlueShield Advantage DualPrime | CareFirst, Inc. | 8,599 | 67 | 1 | — | 16 | 2% |
| H2241 Golden State | MacArthur Court Acquisition Corp | — | 67 | 1 | −3 | 16 | 2% |
| H2108 HealthSpring | Health Care Service Corporation | 12,841 | 68 | 1 | −1 | 15 | 4% |
| H1692 Aetna Medicare | CVS Health Corporation | 21,626 | 68 | 1 | −1 | 15 | 4% |
| H4227 VISTA Health Plan Inc. | Independence Health Group, Inc. | 23,267 | 68 | 1 | 0 | 15 | 4% |
| H1416 Wellcare | Centene Corporation | 55,466 | 68 | 1 | −2 | 15 | 4% |
| H7678 Molina Healthcare of Texas, Inc. | Molina Healthcare, Inc. | 2,963 | 69 | 2 | +1 | 14 | 5% |
| H9190 Gateway Health Plan Of Ohio, Inc. | Gateway Health Plan, LP | — | 69 | 2 | 0 | 14 | 5% |
| H3923 Capital Blue Cross | CAPITAL BLUE CROSS | 42,318 | 69 | 2 | −1 | 14 | 5% |
| H2758 Behealthy Florida, Inc. | Guidewell Mutual Holding Corporation | — | 70 | 2 | 0 | 13 | 6% |
| H5649 Central Health Medicare Plan | Molina Healthcare, Inc. | 30,678 | 70 | 2 | 0 | 13 | 6% |
| H3814 ATRIO Health Plans | ATRIO Health Plans | 1,997 | 70 | 2 | −2 | 13 | 6% |
| H0710 UnitedHealthcare | UnitedHealth Group, Inc. | 45,292 | 70 | 2 | +1 | 13 | 6% |
| H0571 CCHP (Chinese Community Health Plan) | Chinese Hospital Association | 5,714 | 70 | 2 | +1 | 13 | 6% |
History
| Star year | Code | Name | Measured | Weight | Source |
|---|---|---|---|---|---|
| 2022 | C12 | Rheumatoid Arthritis Management | 01/01/2020 – 12/31/2020 | 1 | HEDIS |
| 2021 | C16 | Rheumatoid Arthritis Management | 01/01/2018 – 12/31/2018 | 1 | HEDIS |
| 2020 | C16 | Rheumatoid Arthritis Management | 01/01/2018 – 12/31/2018 | 1 | HEDIS |
| 2019 | C17 | Rheumatoid Arthritis Management | 01/01/2017 – 12/31/2017 | 1 | HEDIS |
| 2018 | C17 | Rheumatoid Arthritis Management | 01/01/2016 – 12/31/2016 | 1 | HEDIS |
| 2017 | C17 | Rheumatoid Arthritis Management | 01/01/2015 - 12/31/2015 | 1 | HEDIS |
| 2016 | C17 | Rheumatoid Arthritis Management | 01/01/2014 - 12/31/2014 | 1 | HEDIS |
| 2015 | C19 | Rheumatoid Arthritis Management | 01/01/2013 - 12/31/2013 | 1 | HEDIS |